Selectivity profile of the α2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat-Reference-Cited by-同舟云学术

Selectivity profile of the α2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat

Published:1992-03 Issue:2 Volume:213 Page:205-212
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Berridge Timothy L.,Doxey John C.,Roach Alan G.,Smith Colin F.C.

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. Pharmacological characterization of the hyperglycaemia induced by alpha-2-adrenoceptor agonists;Angel;J. Pharmacol. Exp. Ther.,1988

2. Some quantitative uses of drug antagonists;Arunlakshana;Br. J. Pharmacol. Chemother.,1959

3. The physiological and pharmacological role of presynaptic and β-adrenoceptors in man;Brown;Br. J. Clin. Pharmacol.,1985

4. Effect of alpha-adrenergic blockade on insulin secretion in man;Buse;Metabolism,1970

5. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2-adrenoceptor stimulatory properties of cirazoline (LD 3098), a potent alpha-1-adrenoceptor agonist in dogs and rats;Cavero;J. Pharmacol. Exp. Ther.,1982

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering Imidazoline Off‐targets by Fishing in the Class A of GPCR field;Molecular Informatics;2020-03-10

2. Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α 2 ‐adrenoceptors in mice;Diabetes, Obesity and Metabolism;2019-11-07

3. Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?;Diabetologia;2012-08-18

4. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes;Bioorganic & Medicinal Chemistry;2006-11

5. Contrasting Metabolic Effects of Antihypertensive Agents;Journal of Pharmacology and Experimental Therapeutics;2003-10-13